The Liver Lab

  • Chapter on book
  • Full Paper
  • Reviews and Editorials

Nonalcoholic fatty liver disease: A wide spectrum disease

Rosso N, Bellentani S

Chapter of 'Liver Diseases'

Springer book

2020

lcnRNA-mediated regulation of acquired chemoresistance in HCC

DiStefano J, Sukowati CHC

Chapter of ‘The Chemical Biology of Long Noncoding RNAs

Springer book

2020

Heterogeneity of hepatic cancer stem cells

Sukowati CHC

Chapter of 'Stem Cells Heterogeneity in Cancer"

Adv Exp Med Biol 2019, Vol. 1139 (ed: A. Birbrair)
 
Springer Nature

2019

 

A hypothesis for using pathway genetic load analysis for understanding complex outcomes in bilirubin encephalopathy

Riordan SM,  Bittel DC, Le Pichon JP, Gazzin S, Tiribelli C, Watchko JF, Wennberg RP, Shapiro SM

Biology of Brain Disorder

Frontiers Cellular Neuroscience

2018

 

Physiology of the liver

Bellarosa C, Tiribelli C

Handbook of gastroenterology and liver diseases

Minerva Medica

2016

Akinetic-rigid and tremor-dominant Parkinson's disease: Two distinct cognitive and behavioral evolutions

Moretti R, Sartori A, Fantini J, Gazzin S

In "Horizons in Neuroscience Research" Volume 18

Nova Science Publishers, Inc

2015

Gait Pathway in Subcortical Vascular Dementia and in Alzheimer’s Disease

Moretti R, Sartori A, Baso B, Gazzin S

In "Alzheimer's Disease - Challenges for the Future" Chapter 11

InTech, DOI: 10.5772/59834, ISBN 978-953-51-2137-4

2015

 

Alcohol and nutrition as risk factors for chronic liver disease

Bellentani S, Tiribelli C, Bedogni G

Nutrition and Health by R.R. Watson et al. (eds.), Springer Science+Business Media New York

2013

Bilirubin metabolism and transport

Bellarosa C, Muchova L,Vitek L, Tiribelli C.

In “Care of the Jaundiced Neonate” by David Stevenson et al(eds), McGraw Hill Companies, Inc.

2012

Disturbances of bilirubin metabolism

Bellarosa C and Tiribelli C

In “Textbook of Clinical Gastroenterology and Hepatology, Second Edition” Wiley Online Library

2012

Cytotoxicity is predicted by unbound and not total bilirubin concentration

Calligaris SD, Bellarosa C, Giraudi P, Wennberg RP, Ostrow JD, Tiribelli C.

Pediatr Res., Nov;62(5):576-80

2007

 

Bilirubin-induced cell toxicity involves PTEN activation through an APE1/Ref-1-dependent pathway

Cesaratto L, Calligaris SD, Vascotto C, Deganuto M, Bellarosa C, Quadrifoglio F, Ostrow JD, Tiribelli C, Tell G.

J Mol Med. Oct;85(10):1099-112. Epub 2007 May 4

2007

 

Suppressor ofcytokine signaling 3 (SOCS3) expression and hepatitis C virus-related chronichepatitis: Insulin resistance and response to antiviral therapy

Persico M, Capasso M, Persico E, Svelto M, Russo R, Spano D, Crocè L, La Mura V, Moschella F, Masutti F, Torella R, Tiribelli C, Iolascon A.

Hepatology, Oct;46(4):1009-15

2007

 

Spirometric reference values for children and adolescents from Kazakhstan

Facchini F, Fiori G, Bedogni G, Galletti L, Ismagulov O, Ismagulova A, Sharmanov T, Tsoy I, Belcastro MG, Rizzoli S, Goldoni M.

Ann Hum Biol. Sep-Oct;34(5):519-34

2007

 

Predictors of non-alcoholic fatty liver disease in obese children

Sartorio A, Del Col A, Agosti F, Mazzilli G, Bellentani S, Tiribelli C,Bedogni G.

Eur J Clin Nutr. Jul;61(7):877-83. Epub 2006 Dec 6

2007

 

Drug-induced acute cholestatic liver damage in a patient with mutation of UGT1A1

Rigato I, Cravatari M, Avellini C, Ponte E, Crocè SL, Tiribelli C.

Nat Clin Pract Gastroenterol Hepatol., Jul;4(7):403-8.

2007

 

Abnormal apolipoprotein B pre-mRNA splicing inpatients with familial hypobetalipoproteinaemia

Di Leo E, Magnolo L, Lancellotti S, Crocè L, Visintin L, Tiribelli C,Bertolini S, Calandra S, Tarugi P.

J Med Genet., Mar;44(3):219-24. Epub 2006 Dec 8.

2007

 

Role of multidrug resistance-associated protein 1 expression in the in vitrosusceptibility of rat nerve cell to unconjugated bilirubin

Falcão AS, Bellarosa C, Fernandes A, Brito MA, Silva RF, Tiribelli C, Brites D.

Neuroscience, Feb 9;144(3):878-88. Epub 2006 Dec 4

2007

 

Subcellular localization ofAPE1/Ref-1 in human hepatocellular carcinoma: possible prognostic significance

Di Maso V, Avellini C, Crocè LS, Rosso N, Quadrifoglio F, Cesaratto L, CodarinE, Bedogni G, Beltrami CA, Tell G, Tiribelli C.

Mol Med. Jan-Feb;13(1-2):89-96

2007

 

Development and validation of a food frequency questionnaire for the assessment of dietary total antioxidant capacity

Pellegrini N, Salvatore S, Valtueña S, Bedogni G, Porrini M, Pala V, Del Rio D, Sieri S, Miglio C, Krogh V, Zavaroni I, Brighenti F.

J Nutr. Jan;137(1):93-8. Erratum in: J Nutr. 2007 Jun;137(6):1499

2007

 

Transcutaneous bilirubin measurements: useful, but also reproducible?

Dani C, Hulzebos CV, Tiribelli C

Pediatr Res. 2020. doi: 10.1038/s41390-020-01242-3.

2020

Elastography: where are we now?

Giuffré M, Colecchia A, Crocé LS

Minerva Gastroenterol Dietol. 2020. doi: 10.23736/S1121-421X.20.02773-7.

2020

The role of bilirubin and other “yellow players” in neurodegenerative diseases

Jayanti S, Vitek L, Tiribelli C, Gazzin S

Antioxidants. 9(9):900. doi: 10.3390/antiox9090900.

2020

Bilirubin, Intestinal Integrity, the Microbiome, and Inflammation

Vítek L, Tiribelli C

N Engl J Med 2020 Aug 13;383(7):684-686.doi: 10.1056/NEJMcibr2013250.

2020

HCC occurrence after DAA treatments: Molecular tools to assess the post-treatment risk and surveillance

Pascut D, Pratama MY, Tiribelli C

Hepat Oncol. 2020 Jun 22;7(2):HEP21. doi: 10.2217/hep-2020-0010

2020

Sorafenib resistance in hepatocellular carcinoma: The relevance of genetic heterogeneity

Cabral KL, Tiribelli C, Sukowati CHC

Cancers (Basel). 2020 Jun 15;12(6):E1576. doi: 10.3390/cancers12061576.

2020

Charles E. Ahlfors (1944–2020)

Wennberg RP, Wong RJ, Shapiro SM, Tiribelli C

Pediatr Res. 2020 May 6. doi: 10.1038/s41390-020-0938-y.

2020

MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease

Eslam M, Sanyal AJ, George J, on behalf of an international consensus panel (including Tiribelli C)    

Gastroenterology. 2020 May;158(7):1999-2014.e1. doi: 10.1053/j.gastro.2019.11.312.

2020

A story of liver and gut microbes: how does the intestinal flora affect liver disease? A review of the literature

Giuffrè M, Campigotto M, Campisciano G, Comar M, Crocè LS

Am J Physiol Gastrointest Liver Physiol.318(5):G889-G906 doi: 101152/ajpgi001612019

2020

Sex differences in Non-Alcoholic Fatty Liver Disease: Hints for future management of the disease

Salvoza NC, Giraudi PJ, Tiribelli C, Rosso N

Explor Med. 2020;1:51-74 DOI: https://doi.org/10.37349/emed.2020.00005

2020